EGFR and lung cancer: A recent study by Wang et al. showed that H3K9 demethylation-mediated epigenetic upregulation of BCAT1 can promote tyrosine kinase inhibitor (TKI) tolerance in epidermal growth factor receptor (EGFR)-mutant lung cancer cells (Wang Y. et al., 2019).